Diabetes, Obesity & Metabolism Research

The Studies

Diabetes, obesity, fatty liver disease, and atherosclerosis are among the most common, costly, and preventable of all health problems, and mainly due to dysregulation of lipid, glucose or energy metabolism. Metabolic dysregulation may cause a number of other chronic diseases and conditions. The researchers also aim to build a collaborative internationally-recognized Center of Excellence for fundamental and translational research in diabetes, obesity and metabolism.

A patient’s perspective on diabetes research

Dan shares his experiences living with diabetes, and his hopes for the future thanks to discoveries in research.

VIDEO EXTRA: NEOMED’s Yanqiao Zhang, M.D., says diabetes, obesity, fatty liver disease and atherosclerosis are among the most common, costly and preventable of all health problems. They are mainly due to dysregulation of lipid, glucose or energy metabolism, which may cause a number of other chronic diseases and conditions. Researchers within the Diabetes, Obesity and Metabolism Research Focus Area at NEOMED have expertise in studying bile acid, glucose, lipid and lipoprotein metabolism.

The Statistics

30M+

More than 30 million people in the U.S. have diabetes.

No. 1

By 2030, non-alcoholic steatohepatitis will be the No. 1 reason for liver transplants in the U.S.

42.4%

Obesity prevalence in the United States in 2017-18, according to the CDC.

The Successes

  • Uncovered novel pathogenic mechanisms of NAFLD and atherosclerosis
  • Identified novel targets for treatment of NAFLD, atherosclerosis, and obesity
  • Identified novel mechanisms of bile acid regulation
  • Discovered novel roles that non-lipid factors play in vessel blockage
  • Dr. Chiang is a recipient of a prestigious Merit Award from NIDDK

The Stories

CONTACT

Yanqiao Zhang, M.D.
Director, Diabetes, Obesity & Metabolism Research Focus Area
Phone: 330.325.6693
Email:  yzhang@neomed.edu

Diabetes, Obesity & Metabolism Research

Research at NEOMED